<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник урологии</journal-title><trans-title-group xml:lang="en"><trans-title>Urology Herald</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2024-12-6-38-44</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-978</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Диагностика активности пиелонефрита путём мониторинга электрохимических свойств мочи и динамики медиатора воспаления мочи ИЛ-8</article-title><trans-title-group xml:lang="en"><trans-title>Diagnosis of stone-related pyelonephritis activity by monitoring urine electrochemical properties and dynamics of urinary inflammatory mediator IL–8</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7966-5181</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хотько</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Khotko</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дмитрий Николаевич Хотько, канд. мед. наук</p><p>Саратов</p></bio><bio xml:lang="en"><p>Dmitry N. Khotko, Cand.Sc.(Med.)</p><p>Saratov</p></bio><email xlink:type="simple">dnksar@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4569-9906</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хотько</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Khotko</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анастасия Игоревна Хотько, канд. мед. наук</p><p>Саратов</p></bio><bio xml:lang="en"><p>Anastasia I. Khotko, Cand.Sc.(Med.)</p><p>Saratov</p></bio><email xlink:type="simple">pivovarova-nastya@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3258-8174</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тарасенко</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tarasenko</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Артём Игоревич Тарасенко, канд. мед. наук</p><p>Москва</p></bio><bio xml:lang="en"><p>Artem I. Tarasenko, Cand.Sc.(Med.)</p><p>Moscow</p></bio><email xlink:type="simple">tar-art@ya.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2876-9607</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попков</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Popkov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владимир Михайлович Попков, д-р мед. наук, профессор</p><p>Саратов</p></bio><bio xml:lang="en"><p>Vladimir M. Popkov, DrSc. (Med.), Full Prof.</p><p>Saratov</p></bio><email xlink:type="simple">popkov.vm@staff.sgmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Саратовский государственный медицинский университет им. В. И. Разумовского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Razumovsky Saratov State Medical University (SSMU)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский&#13;
университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>01</month><year>2025</year></pub-date><volume>12</volume><issue>6</issue><fpage>38</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хотько Д.Н., Хотько А.И., Тарасенко А.И., Попков В.М., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Хотько Д.Н., Хотько А.И., Тарасенко А.И., Попков В.М.</copyright-holder><copyright-holder xml:lang="en">Khotko D.N., Khotko A.I., Tarasenko A.I., Popkov V.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/978">https://www.urovest.ru/jour/article/view/978</self-uri><abstract><sec><title>   Введение</title><p>   Введение. Перкутанная нефролитотрипсия (ПНЛТ) является широко используемым малоинвазивным методом лечения камней почек из-за небольшой травматичности и быстрого восстановления пациентов. Одним из наиболее серьёзных осложнений, возникающих после ПНЛТ, является манифестация пиелонефрита. При этом одним из главных вопросов у практикующих урологов остаётся определение сроков безопасного удаления нефростомического дренажа в послеоперационном периоде.</p></sec><sec><title>   Цель исследования</title><p>   Цель исследования. Оценить возможность применения джоульметрии и динамики мочевого ИЛ-8 в диагностике активности пиелонефрита после ПНЛТ.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. В исследование включены 220 пациентов с нефролитиазом, которым с 2022 года по 2023 год в клинике урологии СГМУ выполнена ПНЛТ. Возраст пациентов — от 25 до 65 лет, среди них 135 (61,3 %) женщин и 85 (38,6 %) мужчин. Группа контроля — 30 здоровых лиц в возрастном диапазоне 24 – 67 лет, 18 (60 %) женщин, 12 (40 %) мужчин. У пациентов с пиелонефритом после оперативного вмешательства и в группе контроля изучали динамику лейкоцитурии, уровень ИЛ-8 в моче, а также проводили электрохимическое исследование мочи джоульметрическим методом по запатентованной методике.</p></sec><sec><title>   Результаты</title><p>   Результаты. При анализе уровней лейкоцитурии, ИЛ-8 мочи, и работы тока по данным джоульметрии установлено достоверное повышение всех изучаемых параметров на 1-е сутки по сравнению с группой контроля (p &lt; 0,05). Значения изучаемых показателей характеризуются максимальным размахом на 3-и сутки и возвращаются к показателям группы контроля на 5-е сутки. При этом при отсутствии лейкоцитурии на 3-и сутки у большинства пациентов значения работы тока и уровень ИЛ-8 мочи остаются повышенными.</p></sec><sec><title>   Заключение</title><p>   Заключение. Джоульметрическое исследование позволяет определить активность пиелонефрита в послеоперационном периоде, что подтверждается общеклиническими обследованиями и определением ИЛ-8 мочи как маркера воспаления. Применение метода позволяет оптимизировать сроки удаления дренажей в послеоперационном периоде.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Introduction</title><p>   Introduction. Percutaneous nephrolithotripsy is an important minimally invasive method for treating kidney stones. It is appreciated for its low injury rate and quick recovery. However, one of the most serious complications that can occur after this procedure is calculous pyelonephritis. The timing and safe removal of nephrostomy drainage in the postoperative period remain a significant concern for urologists.</p></sec><sec><title>   Objective</title><p>   Objective. To determine the possibility of using joulemetry and monitoring urinary IL-8 levels to diagnose stone-related pyelonephritis activity following percutaneous nephrolithotripsy.</p></sec><sec><title>   Materials &amp; methods</title><p>   Materials &amp; methods. The study involved 220 patients with kidney stones who had percutaneous nephrolithotripsy at the SSMU Urology Clinic in 2022 – 2023. The patients were aged between 25 and 65 years, including 135 women (61.3 %) and 85 men (38.7 %). The control group consisted of 30 healthy people aged 24 to 67 years: 18 women (60 %) and 12 men (40 %). After surgery, electrochemical urine examination using the joulemetric method according to a patented technique was performed for patients with stone-related pyelonephritis and for those in the control group.</p></sec><sec><title>   Results</title><p>   Results. When analysing the urine IL-8 level, leukocyturia in the urine test, and the current operation based on joulemetry data, we observe a significant increase in all studied parameters on day 1 compared to the control group (p &gt; 0.05). The values of the studied indicators reach their peak range by day 3 and return to those of the control group by day 5. At the same time, even if there is no leukocyturia on day three, the values of the current parameter and the urine IL-8 level remain elevated in most patients.</p></sec><sec><title>   Conclusion</title><p>   Conclusion. Joulemetry helps to diagnose the activity of stone-related pyelonephritis in the postoperative period. This is confirmed by general clinical examinations and the determination of urine IL-8 as a marker of inflammation. Using this method allows optimising the timing of drainage removal after surgery.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>перкутанная нефролитотрипсия</kwd><kwd>пиелонефрит</kwd><kwd>джоульметрия</kwd><kwd>ИЛ-8</kwd></kwd-group><kwd-group xml:lang="en"><kwd>percutaneous nephrolithotypy</kwd><kwd>pyelonephritis</kwd><kwd>joulemetry</kwd><kwd>IL-8</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено в рамках выполнения НИР по государственному заданию Минздрава России № 124020300030-9 «Разработка генетических тест-систем для определения предрасположенности к образованию конкрементов определенного состава у пациентов с мочекаменной болезнью»</funding-statement><funding-statement xml:lang="en">The study was conducted as part of the R&amp;D project under the state assignment of the Ministry of Health of Russia No. 124020300030-9 «Development of genetic test systems to determine the predisposition to the formation of concretions of a certain composition in patients with urolithiasis»</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ghani KR, Andonian S, Bultitude M, Desai M, Giusti G, Okhunov Z, Preminger GM, de la Rosette J. Percutaneous Nephrolithotomy: Update, Trends, and Future Directions. Eur Urol. 2016;70(2):382-396. DOI: 10.1016/j.eururo.2016.01.047</mixed-citation><mixed-citation xml:lang="en">Ghani KR, Andonian S, Bultitude M, Desai M, Giusti G, Okhunov Z, Preminger GM, de la Rosette J. Percutaneous Nephrolithotomy: Update, Trends, and Future Directions. Eur Urol. 2016;70(2):382-396. DOI: 10.1016/j.eururo.2016.01.047</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wu WJ, Okeke Z. Current clinical scoring systems of percutaneous nephrolithotomy outcomes. Nat Rev Urol. 2017;14(8):459-469. DOI: 10.1038/nrurol.2017.71</mixed-citation><mixed-citation xml:lang="en">Wu WJ, Okeke Z. Current clinical scoring systems of percutaneous nephrolithotomy outcomes. Nat Rev Urol. 2017;14(8):459-469. DOI: 10.1038/nrurol.2017.71</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Хотько А.И., Хотько Д.Н., Попков В.М., Тарасенко А.И. Оптимизация сроков проведения литотрипсии после дренирования верхних мочевых путей у пациентов с мочекаменной болезнью и обструктивной уропатией. Вестник урологии. 2021;9(3):62-69. DOI: 10.21886/2308-6424-2021-9-3-62-69</mixed-citation><mixed-citation xml:lang="en">Khotko A.I., Khotko D.N., Popkov V.M., Tarasenk A.I. Optimizing the lithotripsy timing after drainage of the upper urinary tract in patients with urolithiasis and obstructive uropathy. Urology Herald. 2021;9(3):62-69. (In Russian). DOI: 10.21886/2308-6424-2021-9-3-62-69</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Григорьев Н.А., Семенякин И.В., Малхасян В.А., Гаджиев Н.К. Мочекаменная болезнь. Урология. 2016;(S2):37-70. eLIBRARY ID: 26006186 EDN: VXCKXF</mixed-citation><mixed-citation xml:lang="en">Grigor’ev N.A., Semenyakin I.V., Malhasyan V.A., Gadzhiev N.K. Urolithiasis. Urologiia. 2016;(S2):37-70. (In Russian). eLIBRARY ID: 26006186 EDN: VXCKXF</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abbott JE, Deem SG, Mosley N, Tan G, Kumar N, Davalos JG. Are we fearful of tubeless percutaneous nephrolithotomy? Assessing the need for tube drainage following percutaneous nephrolithotomy. Urol Ann. 2016;8(1):70-75. DOI: 10.4103/0974-7796.162214</mixed-citation><mixed-citation xml:lang="en">Abbott JE, Deem SG, Mosley N, Tan G, Kumar N, Davalos JG. Are we fearful of tubeless percutaneous nephrolithotomy? Assessing the need for tube drainage following percutaneous nephrolithotomy. Urol Ann. 2016;8(1):70-75. DOI: 10.4103/0974-7796.162214</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JY, Kim KH, Kim MD, Chung DY, Cho KS. Intraoperative patient selection for tubeless percutaneous nephrolithotomy. Int Surg. 2014;99(5):662-668. DOI: 10.9738/INTSURG-D-13-00120.1</mixed-citation><mixed-citation xml:lang="en">Lee JY, Kim KH, Kim MD, Chung DY, Cho KS. Intraoperative patient selection for tubeless percutaneous nephrolithotomy. Int Surg. 2014;99(5):662-668. DOI: 10.9738/INTSURG-D-13-00120.1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Crook TJ, Lockyer CR, Keoghane SR, Walmsley BH. Totally tubeless percutaneous nephrolithotomy. J Endourol. 2008;22(2):267-271. DOI: 10.1089/end.2006.0034</mixed-citation><mixed-citation xml:lang="en">Crook TJ, Lockyer CR, Keoghane SR, Walmsley BH. Totally tubeless percutaneous nephrolithotomy. J Endourol. 2008;22(2):267-271. DOI: 10.1089/end.2006.0034</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Moosanejad N, Firouzian A, Hashemi SA, Bahari M, Fazli M. Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial. Braz J Med Biol Res. 2016;49(4):e4878. DOI: 10.1590/1414-431X20154878</mixed-citation><mixed-citation xml:lang="en">Moosanejad N, Firouzian A, Hashemi SA, Bahari M, Fazli M. Comparison of totally tubeless percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for kidney stones: a randomized, clinical trial. Braz J Med Biol Res. 2016;49(4):e4878. DOI: 10.1590/1414-431X20154878</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Veser J, Fajkovic H, Seitz C. Tubeless percutaneous nephrolithotomy: evaluation of minimal invasive exit strategies after percutaneous stone treatment. Curr Opin Urol. 2020;30(5):679-683. DOI: 10.1097/MOU.0000000000000802</mixed-citation><mixed-citation xml:lang="en">Veser J, Fajkovic H, Seitz C. Tubeless percutaneous nephrolithotomy: evaluation of minimal invasive exit strategies after percutaneous stone treatment. Curr Opin Urol. 2020;30(5):679-683. DOI: 10.1097/MOU.0000000000000802</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zilberman DE, Lipkin ME, de la Rosette JJ, Ferrandino MN, Mamoulakis C, Laguna MP, Preminger GM. Tubeless percutaneous nephrolithotomy -- the new standard of care? J Urol. 2010;184(4):1261-1266. DOI: 10.1016/j.juro.2010.06.020</mixed-citation><mixed-citation xml:lang="en">Zilberman DE, Lipkin ME, de la Rosette JJ, Ferrandino MN, Mamoulakis C, Laguna MP, Preminger GM. Tubeless percutaneous nephrolithotomy -- the new standard of care? J Urol. 2010;184(4):1261-1266. DOI: 10.1016/j.juro.2010.06.020</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Патент РФ на изобретение № 2 812 228 C1, МПК G01N 33/48 (2006.01) G01N 33/487 (2006.01) G01N 33/493 (2006.01) Хотько Д.Н., Хотько А.И., Геращенко С.И., Попков В.М., Тарасенко А.И. Способ электрохимического определения наличия воспалительного процесса при калькулезном пиелонефрите. Ссылка активна на 6. 11. 2024. URL: https://www1.fips.ru/iiss/document.xhtml?faces-redirect=true&amp;id=9b31a4bd692c8ee88aecd31fded60993</mixed-citation><mixed-citation xml:lang="en">Patent RF na izobretenie № 2 812 228 C1, MPK G01N 33/48 (2006.01) G01N 33/487 (2006.01) G01N 33/493 (2006.01) Hot’ko D.N., Hot’ko A.I., Gerashhenko S.I., Popkov V.M., Tarasenko A.I. Sposob jelektrohimicheskogo opredelenija nalichija vospalitel’nogo processa pri kal’kuleznom pielonefrite. Available at November 11, 2024. (In Russian). URL: https://www1.fips.ru/iiss/document.xhtml?faces-redirect=true&amp;id=9b31a4bd692c8ee88aecd31fded60993</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Teh KY, Tham TM. Predictors of post-percutaneous nephrolithotomy sepsis: The Northern Malaysian experience. Urol Ann. 2021;13(2):156-162. DOI: 10.4103/UA.UA_28_20</mixed-citation><mixed-citation xml:lang="en">Teh KY, Tham TM. Predictors of post-percutaneous nephrolithotomy sepsis: The Northern Malaysian experience. Urol Ann. 2021;13(2):156-162. DOI: 10.4103/UA.UA_28_20</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Al Rushood M, Al-Eisa A, Al-Attiyah R. Serum and Urine Interleukin-6 and Interleukin-8 Levels Do Not Differentiate Acute Pyelonephritis from Lower Urinary Tract Infections in Children. J Inflamm Res. 2020;13:789-797. DOI: 10.2147/JIR.S275570</mixed-citation><mixed-citation xml:lang="en">Al Rushood M, Al-Eisa A, Al-Attiyah R. Serum and Urine Interleukin-6 and Interleukin-8 Levels Do Not Differentiate Acute Pyelonephritis from Lower Urinary Tract Infections in Children. J Inflamm Res. 2020;13:789-797. DOI: 10.2147/JIR.S275570</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Krzemień G, Szmigielska A, Turczyn A, Pańczyk-Tomaszewska M. Urine interleukin-6, interleukin-8 and transforming growth factor β1 in infants with urinary tract infection and asymptomatic bacteriuria. Cent Eur J Immunol. 2016;41(3):260-267. DOI: 10.5114/ceji.2016.63125</mixed-citation><mixed-citation xml:lang="en">Krzemień G, Szmigielska A, Turczyn A, Pańczyk-Tomaszewska M. Urine interleukin-6, interleukin-8 and transforming growth factor β1 in infants with urinary tract infection and asymptomatic bacteriuria. Cent Eur J Immunol. 2016;41(3):260-267. DOI: 10.5114/ceji.2016.63125</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
